Cargando…
Anti-Toxoplasma gondii Effects of a Novel Spider Peptide XYP1 In Vitro and In Vivo
Toxoplasmosis, caused by an obligate intracellular parasite Toxoplasma gondii, is one of the most prevalent zoonoses worldwide. Treatments for this disease by traditional drugs have shown numerous side effects, thus effective alternative anti-Toxoplasma strategies or drugs are urgently needed. In th...
Autores principales: | Liu, Yuan, Tang, Yaqin, Tang, Xing, Wu, Mengqi, Hou, Shengjie, Liu, Xiaohua, Li, Jing, Deng, Meichun, Huang, Shuaiqin, Jiang, Liping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392294/ https://www.ncbi.nlm.nih.gov/pubmed/34440138 http://dx.doi.org/10.3390/biomedicines9080934 |
Ejemplares similares
-
Correction: Liu et al. Anti-Toxoplasma gondii Effects of a Novel Spider Peptide XYP1 In Vitro and In Vivo. Biomedicines 2021, 9, 934
por: Liu, Yuan, et al.
Publicado: (2022) -
Evaluation of the anti-Toxoplasma gondii Activity of Hederagenin in vitro and in vivo
por: Zhang, Run-Hui, et al.
Publicado: (2021) -
Anti-Toxoplasma gondii Effects of Lipopeptide Derivatives of Lycosin-I
por: Liu, Xiaohua, et al.
Publicado: (2023) -
Spider venom peptides as potential drug candidates due to their
anticancer and antinociceptive activities
por: Wu, Ting, et al.
Publicado: (2019) -
Animal venoms: a novel source of anti-Toxoplasma gondii drug candidates
por: Yang, Dongqian, et al.
Publicado: (2023)